LINC01162

Across TCGA pan-cancer cohorts, LINC01162 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01162’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01162 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01162 is over-expressed in tumor.

LUSC, HNSC, and STAD are the cancer types where LINC01162 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01162 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.185	.022	2	view →
HNSC	Male	All	+0.108	.037	2	view →
STAD	All	All	+0.060	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01162–LUSC

Open the LUSC breakdown →